摘要
虽然最近的证据已经出现阿尔茨海默病(AD)和遗忘型轻度认知功能障碍(aMCI)患者显示区域脑发育异常和脑网络的拓扑变性,我们理解在AD和aMCI患者的大脑网络的拓扑结构影响白质纤维异常是仍然浅陋。在这项研究中,我们调查在AD和aMCI患者的区域容积畸变和全局异常。结果表明,一种广泛分布在灰质和白质萎缩的AD和aMCI组。特别是,AD患者和正常对照相比,aMCI与纤维长度长弱连接(NC)组,由各向异性分数(FA)评估。此外,所有三组的脑网络表现出显着的经济小世界特性。有趣的是,拓扑特征估计从二进制的大脑网络没有表现出显著的群体效应,说明在AD和aMCI保持最佳的拓扑结构具有正在退化的趋势。然而,在足总加权脑网络的AD和aMCI患者中,观察到显着较长的特征路径长度,提示功能性的全球一体化。此外,特征路径长度的异常与认知功能障碍的临床评分呈负相关。因此,结果表明,在加权脑网络的广告的拓扑改变引起的损失与长纤维长度的连通性。我们的研究结果提供了新的见解,在AD中的脑网络的改变,并可能表明脑网络指标的预测值作为生物标志物的疾病发展。
关键词: 阿尔茨海默氏病,遗忘型轻度认知功能障碍,脑组织,弥散张量成像,大脑网络结构,脑白质连通。
Current Alzheimer Research
Title:Disrupted Structural Brain Network in AD and aMCI: A Finding of Long Fiber Degeneration
Volume: 12 Issue: 6
Author(s): Rong Fang, Xiao-Xiao Yan, Zhi-Yuan Wu, Yu Sun, Qi-Hua Yin, Ying Wang, Hui-Dong Tang, Jun-Feng Sun, Fei Miao and Sheng-Di Chen
Affiliation:
关键词: 阿尔茨海默氏病,遗忘型轻度认知功能障碍,脑组织,弥散张量成像,大脑网络结构,脑白质连通。
摘要: Although recent evidence has emerged that Alzheimer’s disease (AD) and amnestic mild cognitive impairment (aMCI) patients show both regional brain abnormalities and topological degeneration in brain networks, our understanding of the effects of white matter fiber aberrations on brain network topology in AD and aMCI is still rudimentary. In this study, we investigated the regional volumetric aberrations and the global topological abnormalities in AD and aMCI patients. The results showed a widely distributed atrophy in both gray and white matters in the AD and aMCI groups. In particular, AD patients had weaker connectivity with long fiber length than aMCI and normal control (NC) groups, as assessed by fractional anisotropy (FA). Furthermore, the brain networks of all three groups exhibited prominent economical small-world properties. Interestingly, the topological characteristics estimated from binary brain networks showed no significant group effect, indicating a tendency of preserving an optimal topological architecture in AD and aMCI during degeneration. However, significantly longer characteristic path length was observed in the FA weighted brain networks of AD and aMCI patients, suggesting dysfunctional global integration. Moreover, the abnormality of the characteristic path length was negatively correlated with the clinical ratings of cognitive impairment. Thus, the results therefore suggested that the topological alterations in weighted brain networks of AD are induced by the loss of connectivity with long fiber lengths. Our findings provide new insights into the alterations of the brain network in AD and may indicate the predictive value of the network metrics as biomarkers of disease development.
Export Options
About this article
Cite this article as:
Rong Fang, Xiao-Xiao Yan, Zhi-Yuan Wu, Yu Sun, Qi-Hua Yin, Ying Wang, Hui-Dong Tang, Jun-Feng Sun, Fei Miao and Sheng-Di Chen , Disrupted Structural Brain Network in AD and aMCI: A Finding of Long Fiber Degeneration, Current Alzheimer Research 2015; 12 (6) . https://dx.doi.org/10.2174/1567205012666150530201349
DOI https://dx.doi.org/10.2174/1567205012666150530201349 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein-Protein Interactions and Subunit Composition of Ion Channels
CNS & Neurological Disorders - Drug Targets Navigating the Sea Changes in Patent Law to Successfully Build Value
Technology Transfer and Entrepreneurship (Discontinued) Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: Ion Channels as a Target for Drug Design )Executive Editor: Kwok-Keung Tai)]
Current Pharmaceutical Design Subacute Fluoxetine Reduces Signs of Hippocampal Damage Induced by a Single Convulsant Dose of 4-Aminopyridine in Rats
CNS & Neurological Disorders - Drug Targets Screening the Receptorome Yields Validated Molecular Targets for Drug Discovery
Current Pharmaceutical Design Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects
Current Alzheimer Research The New Antiepileptic Drugs Pharmacological and Clinical Aspects
Current Pharmaceutical Design Extraction, GC-MS Evaluation and Anti-epileptic Potential of Seeds Ethanolic Extract of Putranjiva roxburghii Wall
Central Nervous System Agents in Medicinal Chemistry Phenylbutyric Acid Protects Against Spatial Memory Deficits in a Model of Repeated Electroconvulsive Therapy
Current Neurovascular Research Mitochondrial Diseases in Childhood
Current Molecular Medicine New Perspectives on the Structure and Function of the Na+ Channel Multigene Family
Current Medicinal Chemistry - Central Nervous System Agents Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases
Current Clinical Pharmacology Importance of Aquaporins in the Physiopathology of Brain Edema
Current Pharmaceutical Design Chemical Biology of mGlu4 Receptor Activation: Dogmas, Challenges, Strategies and Opportunities
Current Topics in Medicinal Chemistry Pharmacological and Biological Activities of Benzazepines: An Overview
Current Bioactive Compounds Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery The Role of Peripheral Benzodiazepine Receptors (PBRs) in CNS Pathophysiology
Current Medicinal Chemistry Preface [Hot topic: Potential Therapeutic Agents for Parkinsons Disease (Executive Editor: Masato Asanuma)]
Current Pharmaceutical Design Simulating the Interactions of Toxins with K+ Channels
Current Pharmaceutical Design